Related references
Note: Only part of the references are listed.Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Ercan Cacan et al.
PLOS ONE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Annual number of lung cancer deaths potentially avertable by screening in the United States
Jiemin Ma et al.
CANCER (2013)
Common gene pathways and families altered by DNA methylation in breast and prostate cancers
Tanya K. Day et al.
ENDOCRINE-RELATED CANCER (2013)
Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases
Frank P. Vendetti et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Denise A. Yardley et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells
Soumik Agarwal et al.
MOLECULAR CANCER (2013)
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
K. Kim et al.
ONCOGENE (2013)
MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer
Akao Zhu et al.
MEDICAL ONCOLOGY (2012)
Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer
Tangfeng Lv et al.
PLOS ONE (2012)
OPERating ON Chromatin, a Colorful Language where Context Matters
Kathryn E. Gardner et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability
Pierre-Olivier Esteve et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines
Carol Kilkenny et al.
JOURNAL OF GENE MEDICINE (2010)
Additive Effects of 5-Aza-2 '-deoxycytidine and Irradiation on Clonogenic Survival of Human Medulloblastoma Cell Lines
Ina Patties et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis
Christina Piperi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression
M. Achour et al.
ONCOGENE (2008)
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort
SA Belinsky et al.
CANCER RESEARCH (2006)
Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation
AH Ting et al.
CANCER RESEARCH (2006)
DNA methylation and histone modifications: teaming up to silence genes
F Fuks
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
MR Rountree et al.
NATURE GENETICS (2000)
Share Paper
